COMMUNIQUÉS West-GlobeNewswire

Twentyeight Health Partners with ŌURA to Expand Access to Comprehensive Contraceptive Care
06/05/2026
Facilitating Clinical Treatment for Women by Incorporating Comprehensive Data and Insights from ŌURA NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Twentyeight Health, the leading provider-led digital women’s healthcare [...]
Better Blend Continues Growth with Second Lexington Location
06/05/2026
Fast-growing Midwest brand brings low-sugar, high-protein menu to the area LEXINGTON, Ky., May 06, 2026 (GLOBE NEWSWIRE) -- Better Blend, a rapidly growing smoothie and bowl brand, opened its second location in [...]
Hope Air Marks 40 Years of Changing Health Outcomes for Patients Needing to Travel Long Distances for Care
06/05/2026
Hope Air Day 2026 highlights the charity’s role in fulfilling Canada’s promise of universal healthcare TORONTO, May 06, 2026 (GLOBE NEWSWIRE) -- On May 6, Hope Air marks 40 years of helping Canadians who must travel [...]
Tekton Research Appoints Dr. Amit Vijapura as Central Nervous System Key Opinion Leader
06/05/2026
As CNS capabilities expand, Tekton adds seasoned leadership to accelerate growth and execution AUSTIN, Texas, May 06, 2026 (GLOBE NEWSWIRE) -- Tekton Research , a leading multi-site clinical trial organization with 25 [...]
MedWell Ai, Inc Reports Q3 Revenues Of $618,676 And Provides Corporate Update
06/05/2026
CLEARWATER, Fla., May 06, 2026 (GLOBE NEWSWIRE) -- via IBN -- MedWell Ai, Inc, (OTCQB:MWAI) ("Company") is a portfolio company, specializing in AI-driven solutions for B2B markets in pharmaceuticals, healthcare, and [...]
Jito Foundation and Solana Company (NASDAQ: HSDT) Announce Strategic Partnership to Expand Institutional Solana Infrastructure Across Asia-Pacific Region
06/05/2026
Pairing Jito's market layer technology and Solana Company's institutional Pacific Backbone platform intended to advance validator infrastructure and staking solutions across Asia-Pacific MIAMI, May 06, 2026 (GLOBE [...]
NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors
06/05/2026
Sequence LifeScience TM Led Financing to Close on Acquisition of Celularity with Strategic Investment of $5.5 Million LANGHORNE, Pa., May 06, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “ [...]
BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle
06/05/2026
New Nighttime Supplement Targets What Happens — or Fails to Happen — While You Sleep LAS VEGAS, May 06, 2026 (GLOBE NEWSWIRE) -- via IBN — More than 1 in 3 American adults report insufficient sleep — a deficit that [...]
Actuate Therapeutics Announces Key Appointment of Industry Veteran to Board of Directors
06/05/2026
Martin Huber, MD brings deep expertise in oncology drug development, regulatory strategy, and commercialization of novel therapies CHICAGO and FORT WORTH, Texas, May 06, 2026 (GLOBE NEWSWIRE) -- Actuate Therapeutics, [...]
Trading by management and close relations of management
06/05/2026
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the [...]
Where Executives Are Doubling Down on Their Companies’ Fortunes
06/05/2026
4 Stocks Under $15 Seeing Aggressive Insider Buying Activity DENVER, May 06, 2026 (GLOBE NEWSWIRE) -- 24/7 Market News and NeOnc Technology -- As market participants are sifting through data, one signal often cuts [...]
Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models
06/05/2026
Landmark data positions ERNA-101 as a potential game-changing immunotherapy and a major catalyst for future clinical and shareholder value CAMBRIDGE, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: [...]
Bioxodes presents positive final Phase 2a intracerebral hemorrhage results at ESOC affirming breakthrough potential of BIOX-101
06/05/2026
Final results confirm and build on interim BIRCH results in 23 ICH patients Primary safety endpoint met with no mortality observed Encouraging efficacy signals on all clinical and biomarker endpoints New adaptive [...]
Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
06/05/2026
SOUTH SAN FRANCISCO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of integrin-based therapeutics, [...]
Cristcot Appoints Rayna Herman as President of its Hydrocortisone Acetate Commercial Division
06/05/2026
Ms. Herman is a life sciences executive with extensive experience developing commercialization strategies and building commercial teams AUSTIN, Texas, May 06, 2026 (GLOBE NEWSWIRE) -- Cristcot, a clinical-stage [...]
Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease
06/05/2026
AGOURA HILLS, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the “Company”), a late-stage clinical biopharmaceutical company focused on oncology and rare [...]
CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions
06/05/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 06, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announces that AZD5904, a potent inhibitor of human Myeloperoxidase, originally [...]
CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference
06/05/2026
ZUG, Switzerland and BOSTON, May 06, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the Bank of America Securities 2026 Global [...]
InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares
06/05/2026
Jena, Germany, May 06, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, announced today the [...]

Pages